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Abstract
Background To assess potential risks of new surgical procedures and devices before their introduction into daily practice, 
a prospective risk inventory (PRI) is a required step. This study assesses the applicability of the Health Failure Mode and 
Effects Analysis (HFMEA) as part of a PRI of new technology in minimally invasive gynecologic surgery.
Methods A reference case was defined of a patient with presumed benign leiomyoma undergoing a laparoscopic hysterectomy 
or myomectomy including in-bag power morcellation; however, pathology defined a stage I uterine leiomyosarcoma. Using 
in-bag morcellation as a template, a HFMEA was performed. All steps of the in-bag morcellation technique were identi-
fied. Next, the possible hazards of these steps were explored and possible measures to control these hazards were discussed.
Results Five main steps of the morcellation process were identified. For retrieval bags without openings to accommodate 
instruments inside the bag, 120 risks were identified. Of these risks, 67 should be eliminated. For containment bags with 
openings 131 risks were identified of which 68 should be eliminated. Of the 10 causes most at risk to cause spillage, two 
can be eliminated by using appropriate bag materials. Myomectomy appears to be more at risk for residual tissue spillage 
compared to total hysterectomy.
Conclusion The HFMEA has provided important new insights regarding potential weaknesses of the in-bag morcellation 
technique, particularly with respect to hazardous steps in the morcellation process as well as requirements that bags should 
meet. As such, this study has shown HFMEA to be a valuable method that identifies and quantifies potential hazards of new 
technology.
Keywords Hysterectomy · Laparoscopy · Morcellation · Myomectomy · Sarcoma
A prospective risk inventory (PRI) assesses potential hazards 
of new surgical procedures and devices (henceforth called 
technology) before their introduction in daily practice [1]. 
However, prospectively assessing potential hazards of new 
and therefore unknown technology is challenging and meth-
ods are needed to aid this assessment.
The Failure Mode and Effects Analysis (FMEA) is a step-
by-step method, performed by a group of people involved 
in the process, aiming to identify failure modes and their 
effects before new technology is introduced in daily prac-
tice. Failure modes are manners in which a process may 
fail, and the effects analysis examines the consequences of 
these failures. It was developed in 1949 to prospectively 
evaluate problems that might occur from malfunctioning of 
new military systems [2]. Due to its prospective nature, the 
conclusions are based on inductive reasoning. Nowadays, 
an FMEA is an important tool in safety and reliability engi-
neering of consumer products, such as the car industry. The 
FMEA was adapted to also suit healthcare requirements: 
the Health Failure Mode and Effects Analysis (HFMEA). 
and Other Interventional Techniques 
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However, experience with this method as part of a PRI is 
limited [3, 4].
The goal of our study was to assess the applicability of 
the HFMEA for new technology in gynecology. We used the 
efficacy of in-bag morcellation, with respect to the preven-
tion of tissue spillage during morcellation, as a template for 
this method. Currently in minimally invasive gynecologic 
surgery (MIGS), in-bag morcellation is nearly regarded as 
the new gold standard for morcellation procedures to over-
come the past safety issues regarding the spread of potential 
malignant tissue. The results of in vitro tests regarding the 
efficacy of containing tissue are favorable and the clinical 
feasibility has been demonstrated [5–8]. However, the onco-
logical safety has yet to be proven. Furthermore, compara-
tive trials are no longer ethically feasible, and prospective 
clinical data will only become available in several years. In 
theory, the HFMEA procedure overcomes these shortcom-
ings of standard research methodology and provides neces-
sary safety information of the in-bag morcellation technique 
in its early phase of implementation in daily clinical practice.
Materials and methods
The HFMEA was performed according to the instructions 
of the prospective risk analysis system developed by the 
Department of Veterans Affairs, National Center for Patient 
Safety [3].
The analysis consisted of 5 steps: choosing a subject, 
assembling a team for the analysis, describing the complete 
process of the subject of interest, performing a hazard analy-
sis of the entire process, and finally resolving all serious 
hazards.
Step 1: choosing the subject
To maintain a workable analysis of the subject of interest, 
it should be defined as precise as possible. This allows the 
number of actions and potential hazards to be limited to the 
ones that are most essential to the subject. For our study, 
a fictional case was defined of a patient with undiagnosed 
stage I uterine leiomyosarcoma, undergoing a laparoscopic 
hysterectomy (LH) or myomectomy (LM) including in-bag 
power morcellation for presumed benign leiomyoma. This 
scenario was chosen as in theory these patients are most 
likely harmed by the occurrence of spillage of malignant 
cells due to an immediate upstaging of the disease, resulting 
in a significantly worse prognosis. Our focus being on spill-
age, risks considered inherent to all (laparoscopic) surgi-
cal procedures were excluded from the scope of the present 
study.
Step 2: assembling the team
A team is assembled representing most of the health care 
workers who are involved with the subject of interesting. 
An expert in the subject and a team leader are appointed. 
The expert helps explaining the process, and the team leader 
chairs the meetings. Novices to the process are also part of 
the team to promote an unbiased critical view of current 
practice.
Step 3: describing the in‑bag morcellation process
Next, the studied subject is graphically described in a flow 
diagram. The main steps are defined and then for each main 
step the sub-steps are identified. Two types of morcellation 
bags were assessed: regular specimen retrieval bags without 
openings to accommodate instruments thus consequently in 
need of iatrogenic breach of bag integrity, and containment 
bags equipped with openings to accommodate a camera or 
instrument. Furthermore, morcellation after LH and after 
LM was evaluated.
Step 4: hazard analysis
For the complete process as determined in step 3, all pos-
sible hazards (the so-called failure modes, meaning how 
and why a process might fail) are identified. To rank these 
hazards from most to least serious, these failure modes are 
scored for their impact on patient health or safety (‘severity’) 
and their chance of occurring (‘probability’). By multiply-
ing the scores for severity and probability, a hazard score 
is calculated: high scores correspond with serious hazards. 
Severity was classified according to the following 4 catego-
ries: recovery without intervention (1 point), intervention 
needed for recovery (2 points), permanent damage or loss 
of function (3 points), and death (4 points) [9] (Table 1). 
To maximize results of our analysis, any kind or amount of 
tissue spread or leakage was considered potentially lethal. 
‘Probability’ was defined as occurring in less than 1000 pro-
cedures (1 point), between 1 in 100 and 1000 procedures (2 
points), between 1 in 10 and 100 procedures (3 points), and 1 
Table 1  Probability and severity score
Pr
ob
ab
ilit
y
Severity
Death Permanent damage
Recovery with 
Reintervention
Spontaneous 
Recovery
> 1/10 16 12 8 4
1/10 – 1/100 12 9 6 3
1/100 –
1/1000 8 6 4 2
< 1/1000 4 3 2 1
Red—hazard score ≥ 8 represents a safety issue and should be 
addressed
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in 10 or more (4 points). A mean hazard score was calculated 
based on the individual scores provided by all participants. 
All participants calculated the hazard scores individually. 
Next, the scores were compared during the meetings and, in 
case of disagreement, discussed and adjusted to reach full 
agreement upon the final hazard score.
Step 5: resolving serious hazards
The HFMEA decision tree is used to identify the failure 
modes that may cause safety issues and should therefore 
be eliminated [3]. In short, this decision tree identifies all 
hazards with a hazard score ≥ 8 as a potential threat that 
needs to be addressed (Red in Table 1). Readily apparent 
hazards and hazards that are already known and controlled 
can be exempted. In addition, the decision tree identifies all 
critical steps in the process (the so-called single point of 
weaknesses, meaning that the technique would fail if this 
single step fails) even with a hazard score < 8.
After identifying these hazards, recommendations were 
formulated in our final meeting to control the most hazard-
ous steps of the in-bag morcellation procedure.
Results
A total of 7 participants were selected for the HFMEA: 1 
gynecologist-oncologist, 1 gynecologist specialized in mini-
mally invasive gynecologic surgery (MIGS), 1 urologist spe-
cialized in minimally invasive surgery, 1 operating room 
(OR) nurse, 2 residents in gynecology, and 1 researcher 
in MIGS. The senior author acted as the expert on the in-
bag morcellation process. An expert in surgical instrument 
safety with experience in HFMEA procedures (ACE) was 
appointed as team leader. To complete the five steps, six 
sessions of 2 h (in total 12 h) were needed, followed by 
additional discussion via email. During the first two ses-
sions, five main steps of the morcellation process were iden-
tified. The first step is inserting the bag in the abdomen. This 
involves unwrapping the bag, handing it to the OR nurse 
and then to the surgeon, until the bag is correctly placed 
inside the abdomen. In step 2, the tissue is placed in the bag, 
meaning that the tissue is grabbed by surgical graspers and is 
manipulated inside the bag. In step 3, the bag is positioned 
for morcellation and inflated with CO2 gas. For specimen 
retrieval bags without extra openings, this also involves 
the iatrogenic puncture of the bag to accommodate surgi-
cal instrument inflation of the bag. In step 4, the tissue is 
morcellated and extracted until all tissue has been removed. 
Finally in step 5, the bag is retrieved from the abdomen 
and the abdomen is inspected for tissue residue. Diagram 1 
demonstrates these steps, as well as the number of sub-steps 
that were found for each main step. As an example, the sub-
steps of main step number 4 (morcellation and extraction of 
tissue) are described in full in the same diagram.
For regular retrieval bags without openings, 37 sub-steps 
and 120 failure modes were identified. Of these failure 
modes, 67 could be eliminated. For containment bags with 
openings, 41 sub-steps and 131 failure modes were identi-
fied. Of these, 68 were identified as possible hazards that 
could be eliminated.
In Table 2, for both bags the moments of the in-bag mor-
cellation procedure most at risk for tissue spillage (meaning 
with the highest hazard scores of 16) are supplied. These 
moments consist mainly of steps where tissue fragments 
may spread throughout the abdomen by instruments that 
Step 1:
Inserting bag
in the abdomen
(11/11)*
Step 2:
Placing tissue
in the bag
(6/9)*
Step 3:
Inflation
of the bag
(6/6)*
Step 4:
Tissue morcellation
and extraction
(8/8)*
Step 5:
Extracting bag and
inspection abdomen
(6/7)*
Sub-steps
4.1: Handing the morcellator to the surgeon by the OR nurse
4.2: Inserting the morcellator with an obturator inside the bag via portal 1
4.3: Removal of the obturator and insertion of grasper inside the morcellator
4.4: Grabbing tissue with grasper. Process is being monitored by camera
4.5: Activating morcellator by pressing ‘on’ switch on instrument
4.6: Pulling tissue through morcellator
4.7: Handing tissue to OR nurse by the surgeon (sterile environment)
4.8: Re-insertion of the grasper
4.9: Repeat step 4.4-4.7 until all tissue is morcellated.
Diagram 1  All main steps of the morcellation process. *Number of sub-steps for each main step: (retrieval bag without sleeves/containment bag 
with sleeves). Arrow (bottom): sub-steps of main step 4 ‘tissue morcellation and extraction’
4360 Surgical Endoscopy (2018) 32:4357–4362
1 3
Ta
bl
e 
2 
 To
p h
az
ar
d s
co
re
s f
or
 bo
th
 ty
pe
 of
 ba
gs
Bo
ld
—
ha
za
rd
s s
pe
cifi
c f
or
 m
yo
m
ec
to
m
y. 
Ita
lic
—
ad
di
tio
na
l s
pe
cifi
c h
az
ar
ds
 fo
r r
eg
ul
ar
 ba
gs
 in
 ne
ed
 of
 pe
rfo
ra
tio
n b
efo
re
 m
or
ce
lla
tio
n
Fa
ilu
re
 m
od
e
Ca
us
e
Po
ss
ib
le 
pr
ev
en
tio
n
Co
nt
am
in
ati
on
 of
 th
e o
ut
sid
e o
f b
ag
Gr
as
pi
ng
 w
ith
 co
nt
am
in
at
ed
 in
str
um
en
ts
In
he
re
nt
 to
 m
yo
m
ec
to
m
y p
ro
ce
du
re
Co
nt
ac
t w
ith
 ex
po
se
d 
m
yo
m
a
Co
nt
am
in
ati
on
 of
 su
rg
ica
l i
ns
tru
m
en
ts 
be
fo
re
 m
or
ce
lla
tio
n
Gr
as
pi
ng
 m
yo
m
a
Co
nt
am
in
ati
on
 of
 th
e a
bd
om
in
al 
ca
vi
ty,
 pe
rit
on
eu
m
, o
r 
ab
do
m
in
al 
wa
ll
Co
nt
ac
t w
ith
 th
e o
ut
sid
e o
f t
he
 b
ag
 th
at
 w
as
 co
nt
am
in
at
ed
 
du
rin
g m
ain
 st
ep
s 1
 an
d 
2
Sp
re
ad
in
g o
f r
em
na
nt
 ti
ss
ue
 by
 ai
rfl
ow
 of
 th
e p
ne
um
op
er
ito
-
ne
um
Re
m
ov
e a
ll 
tis
su
e f
ro
m
 ab
do
m
en
/p
lac
e a
ll 
tis
su
e i
n b
ag
Co
nt
am
in
ati
on
 of
 th
e c
am
er
a a
nd
 su
rg
ica
l i
ns
tru
m
en
ts 
sit
ua
ted
 
in
sid
e t
he
 ba
g
By
 ti
ss
ue
 fr
ag
m
en
ts 
be
in
g s
pr
ea
d d
ur
in
g m
or
ce
lla
tio
n
Cl
ea
n c
am
er
a a
nd
 in
str
um
en
ts 
be
fo
re
 re
-in
se
rti
on
 in
to
 ab
do
m
i-
na
l c
av
ity
 af
ter
 m
or
ce
lla
tio
n p
ro
ce
du
re
Co
nt
am
in
ati
on
 of
 su
rro
un
di
ng
s a
nd
 in
str
um
en
t t
ab
le
By
 ha
nd
lin
g o
f t
he
 co
nt
am
in
ate
d m
or
ce
lla
to
r, 
co
nt
am
in
ate
d 
ca
m
er
a, 
or
 in
str
um
en
ts
Pr
ev
en
t c
on
tac
t a
s m
uc
h a
s p
os
sib
le,
 us
e a
 di
ffe
re
nt
 in
str
um
en
t 
tab
le,
 an
d c
on
sid
er
 ch
an
gi
ng
 gl
ov
es
 in
 ca
se
 of
 fu
ll 
co
nt
ac
t
Oc
cu
rre
nc
e o
f t
iss
ue
 sp
ill
ag
e
Ba
g o
r t
iss
ue
 da
m
ag
e d
ue
 to
 sh
ar
p g
ra
sp
er
s a
nd
 ot
he
r s
ha
rp
 
in
str
um
en
ts
Us
e a
pp
ro
pr
iat
e n
on
-sh
ar
p i
ns
tru
m
en
ts
C
on
ta
m
in
at
io
n 
of
 tr
oc
ar
s
By
 c
on
ta
ct
 w
ith
 ti
ss
ue
 in
si
de
 b
ag
 w
he
n 
tro
ca
r i
s u
se
d 
to
 
pe
rf
or
at
e 
ba
g
Av
oi
d 
us
in
g 
re
gu
la
r b
ag
s w
ith
ou
t a
 p
re
-fa
br
ic
at
ed
 in
se
rt
 fo
r 
ca
m
er
a
C
on
ta
m
in
at
io
n 
of
 th
e 
ab
do
m
in
al
 c
av
ity
, p
er
ito
ne
um
, o
r 
ab
do
m
in
al
lw
al
l
By
 le
ak
ag
e 
of
 ti
ss
ue
 th
ro
ug
h 
pe
rf
or
at
io
n 
du
ri
ng
 e
xt
ra
ct
io
n 
of
 
th
e 
ba
g 
fro
m
 th
e 
ab
do
m
en
4361Surgical Endoscopy (2018) 32:4357–4362 
1 3
have come in contact with the morcellated tissue. Possible 
measures to control these risks are also proposed in Table 2. 
Hazards specific for myomectomy and additional hazards of 
retrieval bags without openings are highlighted in the same 
table. 4 out of 10 causes most at risk to cause spillage are 
specific for myomectomy and do not occur during hysterec-
tomy. Two more causes can be eliminated by avoiding the 
iatrogenic puncture of retrieval bags without openings to 
accommodate the camera or morcellation instrument.
Discussion
Using in-bag morcellation as a template, our study assessed 
the applicability of the HFMEA method as part of a PRI 
for new technology. Although the in-bag morcellation tech-
nique is already widely used in daily clinical practice, the 
HFMEA revealed several possible weaknesses that should 
be addressed to further enhance the safety of this procedure.
All instruments (camera, graspers, portals) used inside 
the bag are a possible source for tissue spillage. In theory, 
when these instruments are later re-introduced into the 
abdominal cavity, they may unintentionally insert tissue rem-
nants that were initially contained in the bag. Also, handling 
these instruments and placing them on the instrument table 
may contaminate the surgical team itself and other instru-
ments. However, in case of sarcoma the oncological effect 
of minimal amounts of spread or leakage, henceforth called 
micro-spillage, into the abdominal cavity is unclear. For 
instance, in endometrial carcinoma the spread of malignant 
cells in the abdominal cavity via the fallopian tubes during 
hysteroscopy does not appear to negatively influence clini-
cal outcome [10–12]. The same might apply to our findings. 
Nonetheless, in theory it seems appropriate to thoroughly 
clean or even change all instruments and surgical gloves 
after morcellation. In the same light, it became clear that 
myomectomy is at higher risk regarding tissue spread com-
pared to hysterectomy. Tissue spillage during myomectomy 
has been demonstrated even without morcellation [13, 14]. 
Therefore in myomectomy, tissue may have spread both dur-
ing and after the excision of the myoma, even before morcel-
lation is performed. This does not occur after (total) hyster-
ectomy, assuming that the integrity of the leiomyosarcomas 
is preserved. It follows that 4 out of 10 causes most at risk 
for spillage can be eliminated when comparing hysterectomy 
to myomectomy (Table 2). It should be stressed, however, 
that the meaning of micro-spillage is unclear and this study 
does not propose to abandon the minimally invasive removal 
of fibroids. Yet in this light, the possible consequences of 
micro-spillage should be further studied to reach a complete 
understanding of the risks of morcellation.
The second main hazard for contamination is failure of 
bag integrity due to sharp instruments handled in or around 
the bag. Yet, this can be easily eliminated. Only materials 
should be used that can withstand forces applied during 
power morcellation, including instrument and tissue manipu-
lation, as well as pressure and airflow caused by insufflation 
of the bag. In addition, bags should remain impermeable to 
tissue cells under these conditions. Furthermore, gynecolo-
gists should be aware of bag integrity failures when using 
their instruments near the bag [5, 15] Finally, the design 
of containment bags should be able to accommodate the 
camera, morcellator, and possibly a third instrument in the 
bag. The intentional puncture of retrieval bags has already 
been shown as possible cause for tissue leakage during in-
bag morcellation [7]. By avoiding this puncture, 2 of the 10 
(LM) and 2 of 6 (LH) main causes for spillage can be elimi-
nated (Table 2). To our knowledge, of the currently avail-
able morcellation bags only one claims to meet the above-
mentioned requirements. This bag was recently permitted to 
market by the FDA [16].
There are some considerations when interpreting the 
results from our study. Firstly, the consequence of micro-
spillage is unclear as discussed. Nevertheless, there is 
increasing evidence that disease outcome is negatively influ-
enced after (all types of) morcellation [17–20]. Next, there 
are limitations regarding the HFMEA.
This method was considered too time consuming in some 
studies and concerns were raised regarding the external 
validity of the prioritizing of hazards in the HFMEA [21, 
22]. The severity and probability of a potential hazard may 
not always be known and must therefore be estimated by the 
team. In addition, hazards may be overlooked altogether. 
On the other hand, the identification of all (sub)steps and 
hazards of a procedure was reliable and reproducible [22]. 
In our opinion, this is the most important component of the 
HFMEA as the identification of such hazards, regardless of 
prioritization, allows adjustments and improvements of the 
assessed technology. Finally, although the HFMEA was time 
consuming, the time we spent is insignificant in relation to 
the time needed to repair adverse events that could have been 
prevented with a thorough prospective evaluation. Indeed, it 
can be questioned if a thorough risk analysis of power mor-
cellation would have resulted in early warnings regarding the 
spill of malignant tissue being taken more seriously [23–27].
In conclusion, this study has demonstrated that the 
HFMEA is a valuable part of a prospective risk inventory 
of new surgical technology. Using in-bag morcellation as a 
template, the HFMEA has provided important new insights 
regarding potential weaknesses of this technique that were 
previously not recognized, even though in-bag morcellation 
is proposed as the new standard for morcellation. In addi-
tion, the recommendations that resulted from the HFMEA 
could be easily implemented in daily clinical practice.
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